Obeticholic Acid-A Pharmacological and Clinical Review
Obeticholic acid (OCA) or 6-alpha-ethyl-chenodeoxycholic acid is a semisynthetic modified bile acid derivative that acts on the farnesoid X receptor (FXR) as an agonist with a higher potency than bile acid. The FXR is a nuclear receptor highly expressed in the liver and small intestine and regulates...
Saved in:
Main Authors: | Caezaan Keshvani (Author), Jonathan Kopel (Author), Hemant Goyal (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
by: Chuangzhen Lin, et al.
Published: (2022) -
A Novel Telescoped Kilogram-Scale Process for Preparation of Obeticholic Acid
by: Cheng-Wei Li, et al.
Published: (2021) -
Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
by: Jiyu Zhou, et al.
Published: (2019) -
Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2018) -
New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
by: Jhaveri MA, et al.
Published: (2017)